Incidental Lewy body disease: clinical comparison to a control cohort.
about
Spatial-orientation priming impedes rather than facilitates the spontaneous control of hand-retraction speeds in patients with Parkinson's diseaseClinicopathological outcomes of prospectively followed normal elderly brain bank volunteers.National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's diseaseEssential tremor and Parkinson's disease: lack of a linkNeuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP?Probable RBD is increased in Parkinson's disease but not in essential tremor or restless legs syndromeThe patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's diseaseIncidental Lewy body disease: electrophysiological findings suggesting pre-clinical Lewy body disordersBrain biochemistry in autopsied patients with essential tremorNational Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.Premotor Parkinson's disease: concepts and definitionsGene expression in the Parkinson's disease brain.Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging.Parkinson disease and incidental Lewy body disease: Just a question of time?Essential tremor is not a neurodegenerative diseaseHigher Prevalence of TDP-43 Proteinopathy in Cognitively Normal Asians: A Clinicopathological Study on a Multiethnic Sample.Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease.Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervationOlfactory dysfunction in incidental Lewy body disease and Parkinson's diseaseCerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects.TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies.Medical treatment of essential tremor.Olfaction as a biomarker in Parkinson's disease.A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials.Milestones in Parkinson's disease--clinical and pathologic features.Premotor symptoms and early diagnosis of Parkinson's disease.Lewy pathology and neurodegeneration in premotor Parkinson's disease.Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson's DiseaseAdvances in Biomarker Research in Parkinson's Disease.Neuropathological basis of nonmotor manifestations of Parkinson's disease.The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.Pathology of Neurodegenerative Diseases.Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function.Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology.Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1.Lewy bodies in essential tremor are no different than in controls.Cognitive changes in prodromal Parkinson's disease: A review.
P2860
Q27313779-56DE74D1-EC03-4CC1-AB21-E6D1CCB24FC3Q33456273-4D551402-B062-46C4-B299-95CFB7783FB3Q34635272-38B69A82-6246-4194-983D-9037EB51E338Q34762107-3F6A1F1A-068D-49E0-AE4A-1A10E1E30135Q35028155-44469B71-1051-4F84-904E-AD56A9F92AB3Q35059012-84E0307C-22C9-4A5F-9AAC-9C83BE062C97Q35089830-C9C5F90F-BB72-44CA-B9AE-1ED72449AF81Q35190139-F06C453A-4078-406C-AFA2-6A0E961328A6Q35680914-7C8A5B33-AE15-40C3-87B3-E0F401F600DFQ35706615-069DAA47-F6BC-40F3-898B-A3E3F6906D13Q35910731-20661C0B-1503-473F-B058-375940E1DA83Q36069691-57C1EAFE-C283-4237-A961-1A1964B6DFC4Q36121377-5C9CA746-03CC-438D-9295-47C96ECB36B3Q36178474-F91B5ABF-5FAA-4B63-893C-A8059DCF652DQ36300086-49B9BA01-6EED-42BF-B40A-E167BF75BD46Q36340954-734BA008-0BE2-4205-86B8-C89B67DE8C55Q36573060-2B2EF4C0-ED69-4057-98A4-2E29DEE7B461Q36626757-9FC5EFD5-887A-489C-8982-C75972101456Q36723152-3EE801F6-3315-425F-A867-6D3B5CAF18CBQ36808303-0750922B-37C9-4114-B5B4-11253FDA546BQ36925296-F5A97CF6-1074-441C-B276-AA79A4B382D7Q36951533-CB9F152C-B75C-47CA-97E8-75F40DAFD9C1Q37723544-A2EC5E72-E82E-4DD4-88FA-2FDD9E448845Q37800097-CCA5500C-77DF-496C-98B7-45586DFF1D96Q37864239-F86B831A-B7D9-4CB3-AE74-69CFF7D8E8FCQ37882587-D2E34A9C-7A73-4FC9-A0DF-267F6989A52DQ37950421-6B766641-2A58-4752-A7E6-F5C4EAA35CF2Q38003064-C2FFC92A-4B0B-4DCC-B064-BED17EB521A8Q38014888-A1ACA95A-117E-495D-A361-0C1DDEF514B4Q38021865-B8725CE3-4897-4CF1-A38A-6946F11E27E4Q38384109-2DF29E65-F64F-4BE2-9291-27B1ACA751BFQ38681599-0FC995FE-DDA4-4EC9-B566-870F6C5C08C8Q38794098-23EABDFA-D9E1-4FC1-AEC8-A6DCE1C32C87Q39052041-272AF1E7-63B9-48A8-A149-04132A2D8E73Q39071493-B6E024F6-7306-45D8-AF66-DE8260A1AB7AQ41974621-660A1668-A965-41A5-87AA-7B2528539CA7Q42501188-2B7D70C8-983D-4F88-A06F-57D9E39B85ECQ46255370-C9EA32EF-45DA-48D5-AA7C-5777B3CB1FC3Q47105176-5C504104-9ED1-4E68-908A-7A24383BA6BFQ47860019-79C9BB55-CEEC-4B7D-AE76-4386D527E0AE
P2860
Incidental Lewy body disease: clinical comparison to a control cohort.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Incidental Lewy body disease: clinical comparison to a control cohort.
@ast
Incidental Lewy body disease: clinical comparison to a control cohort.
@en
Incidental Lewy body disease: clinical comparison to a control cohort.
@nl
type
label
Incidental Lewy body disease: clinical comparison to a control cohort.
@ast
Incidental Lewy body disease: clinical comparison to a control cohort.
@en
Incidental Lewy body disease: clinical comparison to a control cohort.
@nl
prefLabel
Incidental Lewy body disease: clinical comparison to a control cohort.
@ast
Incidental Lewy body disease: clinical comparison to a control cohort.
@en
Incidental Lewy body disease: clinical comparison to a control cohort.
@nl
P2093
P2860
P356
P1433
P1476
Incidental Lewy body disease: clinical comparison to a control cohort.
@en
P2093
Brie Noble
Donald J Connor
Holly A Shill
John N Caviness
Joseph G Hentz
Marwan N Sabbagh
P2860
P304
P356
10.1002/MDS.22971
P407
P577
2010-04-01T00:00:00Z